We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Opvido Shows Promise in Late-Stage Lung Cancer Trial
Opvido Shows Promise in Late-Stage Lung Cancer Trial
Yet another cancer indication may be in sight for Bristol-Myers Squibb’s blockbuster drug Opdivo (nivolumab) based on the latest results from a phase 3 clinical trial.